2 results
Approved WMOCompleted
To determine the specificity of the effects of histamine H1-receptor blockade on different cognitive functions and processes.
Approved WMORecruiting
Primary:• To compare progression free survival (PFS) between Arm A (ociperlimab in combination with tislelizumab) and Arm B (pembrolizumab followed by placebo) in the Intent to Treat (ITT) Analysis Set as assessed by investigators according to…